US$269.7m (up 9.6% from 1Q ...

Omnicell’s ability to take advantage of growth opportunities and develop and commercialize new solutions and enhance existing solutions, (iii) reduction in demand in the capital equipment market ...

Omnicell, Inc. OMCL has witnessed strong momentum ... software licenses, packaging equipment and other supplies. They also include consumables such as medication adherence packaging, labelling ...

Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsKathleen Nemeth - SVP, IRRandall Lipps - ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

Omnicell’s OMCL strength in its SaaS and ... Additionally, there is a substantial demand for adherence packaging equipment outside the domestic market. The company’s international operations ...

Omnicell Inc. (OMCL) reported its first-quarter 2025 earnings, exceeding Wall Street’s expectations with an earnings per share (EPS) of $0.26, surpassing the forecasted $0.21. Despite this ...

Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance Omnicell, Inc. (NASDAQ:OMCL ...

Omnicell Inc. (OMCL) reported its first-quarter 2025 earnings, exceeding Wall Street’s expectations with an earnings per share (EPS) of $0.26, surpassing the forecasted $0.21. Despite this positive ...

Omnicell delivers solid first quarter financial results Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and ...